First published online 20 May 2003
doi: 10.1242/jcs.00479
Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells
Ansgar Santel*,1,
Stephan Frank2,4,
Brigitte Gaume2,
Michael Herrler3,
Richard J. Youle2 and
Margaret T. Fuller1,
1 Departments of Developmental Biology and Genetics, Stanford University School
of Medicine, Stanford, CA 94305, USA
2 Biochemistry Section, Surgical Neurology Branch, NINDS, National Institutes of
Health, Bethesda, MD 20892, USA
3 BD Biosciences CLONTECH, Palo Alto, CA 94303, USA
4 Department of Neuropathology, University of Bonn, 53105 Bonn, Germany

View larger version (86K):
[in a new window]
|
Fig. 1. Human mitofusin homologues Mfn1 and Mfn2 aligned with Drosophila
Fzo (ClustalW and Boxshade). Black shading: amino acid identity. Gray shading:
amino acid similarity. Asterisks: G1, G2, G3, G4 (four motifs of the signature
GTPase domain). Thick brackets: region used to generate Mfn1-specific
antibodies. Parentheses: internal peptide sequence used as imunogen for
Mfn2-specific antibodies.
|
|

View larger version (82K):
[in a new window]
|
Fig. 2. Differential expression of Mfn1 and Mfn2 mRNAs in human tissues. (A) Human
multiple tissue northern (Clontech) probed with Mfn1- or Mfn2-specific probes
or actin (loading control). (B) RNA-chip carrying human polyA-mRNA from 128
different tissues or cell types. Arrows and boxes highlight cases of
differential expression between Mfn1 and Mfn2. Elevated Mfn2 mRNA in heart
tissues (double arrows).
|
|

View larger version (25K):
[in a new window]
|
Fig. 3. Mfn1 and Mfn2 protein expression in different cell lines, human and mouse
tissues. (A) Extracts from COS-7 cells transiently transfected with various
Mfn1 (GFP-Mfn1, Mfn1, antisense-Mfn1) and Mfn2- (Mfn2-myc and
Mfn2 1-96-myc) expression constructs (as
indicated) analyzed by western blotting using anti-Mfn1 or anti-myc
antibodies. (B) Human Mfn1 protein detected as an 86 kDa band (arrow) in
extracts from adult human heart, kidney (both from Clontech) and postnuclear
supernatant from HeLa cell extracts probed with anti-Mfn1. Unspecific
crossreacting band (asterisk). Same gel probed with anti-Tom40 antibodies as
loading control (lower panel). (C) Mfn2 is abundantly expressed in human
heart. Total cell extracts from yeast containing pGal1::Mfn2 plasmid and grown
in either dextrose- or galactose-containing medium (left two lanes). Protein
extracts from human kidney or heart (right two lanes) probed with
Mfn2-specific polyclonal antibodies (two different exposures shown). Mfn2 runs
as a doublet at around 86 kDa (arrow). Parallel loadings of same extracts
probed with anti-Mfn1 antibodies, or anti-Tom40 and anti-actin as loading
controls (lower three panels).
|
|

View larger version (26K):
[in a new window]
|
Fig. 4. Mfn1 co-fractionates with mitochondria and participates in a high molecular
weight complex. (A) Mfn1 co-fractionated with the mitochondrial outer membrane
proteins TOM40 and porin. Postnuclear protein extracts from HeLa cells and
mouse heart were fractionated by differential centrifugation, subjected to
SDS-PAGE, and then western blots were probed with anti-Mfn1, anti-TOM40,
anti-porin and anti-actin. Total, postnuclear extract. PMS, postmitochondrial
supernatent, depleted of mitochondria. Mito, crude mitochondrial pellet. (B)
Migration of Mfn1 in a 350 kDa complex. Mitochondrial extracts derived from
human HL-60 cells were solubilized with digitonin and fractionated through a
Superose-6 gel filtration column. Fractions were analyzed by western blotting
using anti-Mfn1 antibodies, void volume to the left; mobility of marker
proteins (arrows).
|
|

View larger version (89K):
[in a new window]
|
Fig. 5. Overexpression of Mfn1 in COS-7 cells caused formation of grape-like
clusters with enlarged mitochondria. COS-7 cells transiently transfected with
(A,C-E) GFP-Mfn1 or (B) untagged Mfn1 expression constructs. (A) Confocal
image of live COS-7 cells. Mitochondria visualized with Mitotracker (red).
Transfected cells expressing GFP-Mfn1 (arrows, green). (B) Cells fixed and
stained with anti-Mfn1 (green) and counterstained with anti-cytochrome c
(red). Transfected cell with typical grape-like perinuclear cluster of
mitochondria. (arrow; C-E) High magnification view of cluster-of-grape-like
mitochondrial network formed after transient transfection with GFP-Mfn1
(green); mitochondrial intermembrane space labeled with anti-cytochrome c
(red). (F) Electron microscope image showing cluster-of-grape-like
mitochondrial network in COS-7 cell transiently transfected with GFP-Mfn1 and
processed for immunogold-labeling using anti-GFP antibodies. Note the
characteristic central space surrounded by tightly packed mitochondria with
enlarged mitochondria at the periphery.
|
|

View larger version (45K):
[in a new window]
|
Fig. 6. Dependence of Mfn1-induced mitochondrial cluster formation on a wild type
Mfn1 GTPase domain. (A) Diagram of wildtype and mutant GFP-Mfn1 expression
constructs. (B-E) Immunofluorescence images of COS-7 cells showing GFP (green)
and counterstained with anti-cytochrome C (red). (B) Cells transiently
transfected with wildtype GFP-Mfn1 (arrows), showing typical clustered
networks with large mitochondria (red) around the periphery. (C,D) Cells from
culture transiently transfected with mutant GFP-Mfn1K88T showing
that the majority of transfected cells have normal appearing mitochondrial
arrays (arrowheads) Higher magnification view. Some transfected cells (30%)
still had clustered mitochondria (arrow), although they did not usually show
the cluster-of-grape morphology. Instead, the GFP and anti-cytochome c
commonly colocalized and the clustered mitochondria commonly lacked the large
regions stained with anti-cytochome c but not GFP. (E) COS-7 cells transiently
transfected with an N-terminal deletion mutant
GFP-Mfn1 GTPase lacking the entire GTPase domain.
Most transfected cells had clustered mitochondria in which the GFP and
anti-cytochome c colocalized and did not show grape-like clusters (arrow).
|
|

View larger version (119K):
[in a new window]
|
Fig. 7. Overexpression of the GTPase G2 motif mutant GFP-Mfn1T109A
caused mitochondrial fragmentation. (A) Live COS-7 cells nine hours after
transient transfection with GFP-Mfn1T109A (green) counterstained
with Mitotracker (red). Arrow, transfected cell. High magnification view of
fragmented mitochondria, showing GFP-Mfn1T109A around the surface
of individual mitochondria stained with mitotracker (Inset). (B) COS-7 cells
transfected with GFP-Mfn1T109A, showing effects of low (arrow) or
high (double arrow) levels of GFP-Mfn1T109A expression. (C) Example
from COS-7 cell culture co-transfected with GFP-Mfn1T109A and
wildtype Mfn1. Samples in B and C imaged by fluorescence of the GFP moiety of
the GFP-Mfn1T109A fusion protein. (D) COS-7 cells from culture
co-transfected with GFP-Mfn1T109A (green) and HIS-tagged wildtype
Mfn1 (Mfn1-V5/HIS) (red, immunofluorescence using anti-HIS-tag antibodies also
labels nuclei). Fine mitochondrial network in a cell expressing
GFP-Mfn1T109A with low levels of Mfn1-V5/HIS (double arrow).
Grape-like mitochondrial cluster in a cell co-expressing
GFP-Mfn1T109A and high levels of V5/HIS-tagged Mfn1 (arrow). Lower
panels: GFP-Mfn1T109A-transfected cell with no detectable
Mfn1-V5/HIS protein, from the same co-transfection experiment.
|
|

View larger version (40K):
[in a new window]
|
Fig. 8. Drp1K38A blocks mitochondrial fragmentation in cells expressing
Mfn1T109A. Mitochondrial morphology visualized by GFP-fluorescence
in representative doubly-transfected COS-7 cells expressing
GFP-Mfn1T109A (green) and HA-tagged Drp1K38A (red
dot-like structures counterstained with anti-HA).
|
|
© The Company of Biologists Ltd 2003